• Please find below the latest version of the program agenda, including accepted oral and poster presentations. You can also download a copy of the program HERE.
  • Missed the 2nd edition? You can view the presentations and the videos on the Infectious Diseases Online.


Last updated: 2017-10-06

Thursday, October 19, 2017

Key note
Chair: Alan Landay 
09:30hBrain-Gut-Microbiota interactions and intestinal health
Wendy Henderson, NINR, NIH, DHHS
Session 1: Pathogenesis
Chairs: Cara Wilson & Stacy Carrington-Lawrence
10:30hMining adaptive immunity to identify disease-promoting microbiota members in HIV
Ivan Vujkovic-Cvijin, National Institutes of Health, Mucosal Immunology Section, USA
11:00hMicrobial colonization of the gut and brain development in infancy
Rebecca Knickmeyer, UNC School of Medicine, UNC-Chapel Hill, USA
11:30hDifferential responses of colonic ILCs to gut commensal bacteria altered during HIV infection (Abstract #: O_01)
Moriah Castleman, USA
11:45hMicrobial dysbiosis does not alter immune activation or disease progression in SIV-infected rhesus macaques (Abstract #: O_02)
Alexandra Ortiz, USA
12:00hDiscussion & Session Evaluation
12:15hGroup Photo & Lunch Break
Session 2: Transmission & Prevention
Chairs: Laurel Lagenaur & Piotr Nowak
13:15hMicrobe: drug interactions and the impact on HIV infection and pathogenesis 
Nichole Klatt, University of Washington, USA
13:45hCervicovaginal microbial dynamics and its impact on HIV acquisition risk
Douglas Kwon, Ragon Institute of MGH, MIT and Harvard, USA
14:15Vaginal lactic acid inhibits production of pro-inflammatory mediators from human cervicovaginal epithelial cells associated with HIV acquisition (Abstract #: O_03)
Gilda Tachedjian, Australia
14:30Discussion & Session Evaluation
14:45Break & Poster Viewing (Abstract #: O_01 - O_04, P_01 - P_08) 
Session 3: GI Tract and Diet
Chairs: Nichole Klatt & Satya Dandekar

Detrimental impact of a high fat diet on the natural history of SIV infection in non-human
Ivona Pandrea, University of Pittsburgh, USA


Milk - guiding the infant microbiome 
Bruce German, University of California, Davis, USA

16:30hUnderstanding complexities of gut microbiome dysbiosis in HIV infected populations using a large cohort (Abstract #: O_04)
Abigail Armstrong, USA
16:45hPlasma tryptophan-kynurenine metabolites are altered with gut microbiota dysbiosis in HIV infection and associated with progression of carotid artery atherosclerosis (Abstract #: O_09)
Qibin Qi, USA
17:00hDiscussion & Session Evaluation

Friday, October 20, 2017

Session 4: Comorbidities
Chairs: Alan Landay & Ronald Collman 
09:00hInflammatory bowel disease (IBD) and colon cancer and microbiome
William DePaolo, University of Washington, USA
09:30hMicrobial metabolites in HIV pathogenesis and comorbidities
Dana Gabuzda, Harvard Medical School, USA
10:00hComposite analysis of bacteriome and virome from HIV/HPV-coinfected pregnant women reveals proxies for intraepithelial lesions and immunodeficiency status (Abstract #: O_05)
Marcelo Soares, Brazil
10:15hDiscussion & Session Evaluation
10:30hBreak & Poster Viewing (Abstract #: O_05 - O_09, P_10 - P_16)
Session 5: Microbiome & Vaccines
Chairs: Que Dang & Angela Malaspina

Aging, the microbiome and vaccine responses
Daria Hazuda, Merck, USA


Mechanisms intersecting microbiota metabolomics with gut epithelial barrier repair in HIV infection
Satya Dandekar, University of California, Davis, USA

12:30hRole of the microbiome in HIV vaccine response heterogeneity
James Kublin, Fred Hutch and University of Washington, USA
13:00hEffect of high-risk sexual behaviour on diversity of the vaginal microbiota and abundance of lactobacillus (Abstract #: O_06)
Jocelyn Wessels, Canada
13:15h Discussion & Session Evaluation
13:30hLunch break
Session 6: Metabolomics Biologic and Technical issues
Chairs: Frederic Bushman & Roger Paredes
14:30hStudying the functional microbiome in vivo in HIV by metaproteomics approaches
Adam Burgener, University of Manitoba, Canada

Fatty acid profiles differ in HIV infection, persist despite suppressive ART, and are associated with immune activation
Nicholas Funderburg, Ohio State University College of Medicine, USA

15:30hModulation of gut microbiota by indoleamine 2,3-dioxygenase 1 inhibitor during antiretroviral suppressed SIV infection in rhesus macaques (Abstract #: O_07)
Zhang Wang, USA
15:45hThe microbial-derived short chain fatty acid butyrate directly and differentially inhibits gut T helper cell subset activation and proliferation (Abstract #: O_08)
Jon Kibbie, USA
16:00hDiscussion & Session Evaluation
16:30hClosing remarks by workshop chair


Paper ref. # TitlePresentation author
P_01Management of neurocognitive impairment in HIV patientsJason Brenchley, Italy
P_02Effects of advanced HIV disease on the dormant blood microbiotaSergio Serrano-Villar, Spain
P_03A role for dysbiotic bacteria in increased gastrointestinal neutrophil lifespan in treated HIV infectionTiffany Hensley-Mcbain, USA
P_04FuMi: A novel functional microbiome tool for metaproteomic datasets identified key bacterial pathways altered with pregnancy Sarah Mutch, Canada
P_05Depot-Medroxyprogesterone Acetate (DMPA) is associated with diversity of the vaginal microbiota and an altered vaginal microenvironment Jocelyn Wessels, Canada
P_06Cloud-based microbiome, metagenomic, and pathogen analysisHsinyi Tsang, USA
P_07Isolation of translocating bacteria in progressive SIV infection of rhesus macaques Jacob Flynn, USA
P_08Innovative pilot program on the diagnosis and management modulation of the diseases caused in the oral microbiomeKishore Shetty, USA
P_10Epidemiology of HIV/AIDS and syphilis among high risk groups in Pakistan Usman Waheed, Pakistan
P_11Promoting and creating awareness of HIV/AIDS in the black african communities in luton, United KingdomNelson Anti, UK
P_12Mobile HIV counselling and testing outreach: a model for community based approach to increasing uptake of HCT and antiretroviral therapy services in Benue State NigeriaGreg Abiaziem, Nigeria
P_13HIV-associated microbiome differences, geography, and inflammationDavid B Gootenberg, USA
P_14Microbiome Profiles of Chronic HIV-1 Infection under HAARTJemal Ali Mahdi, Ethiopia
P_15Molecular Epidemiology of HIV/AIDS in PakistanUsman Waheed, Pakistan
P_16Fecal microbiota composition drives immune activation in HIV-infected individualsCatherine Lozupone, USA